Open AccessReal-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Author(s) -
Sora Kang,
Changhoon Yoo,
So Heun Lee,
Dong Kyu Oh,
Tae Jun Song,
Sang Soo Lee,
Jae Ho Jeong,
Do Hyun Park,
Dong Wan Seo,
JinHong Park,
Dae Wook Hwang,
Ki Byung Song,
Jae Hoon Lee,
Woo Hyung Lee,
Bong Jun Kwak,
Sarang Hong,
Heung-Moon Chang,
BaekYeol Ryoo,
Kyu-Pyo Kim,
Song Cheol Kim
Publication year - 2022
Publication title -
therapeutic advances in medical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 49
eISSN - 1758-8359
pISSN - 1758-8340
DOI - 10.1177/17588359221097190
Subject(s) - medicine , gemcitabine , capecitabine , hazard ratio , neutropenia , gastroenterology , confidence interval , adjuvant , retrospective cohort study , population , pancreatic cancer , oncology , chemotherapy , surgery , cancer , colorectal cancer , environmental health